Three consultant doctors at King Faisal Specialist Hospital in Riyadh applied a new triple treatment for hepatitis C (virus C) to a number of patients, to be the first hospital to use this type of treatment in the Middle East region.
The application, which was initiated by Dr. Hamad Al-Ashqar, Dr. Faisal Aba Al-Khail, and Dr. Al-Moataz, a consultant in diseases and liver transplantation in the hospital, was based on approval to use the treatment based on the permission to start using it from the US Food and Drug Administration in the fall of 2001, according to what it showed Excellent results from drug-related research, which showed a cure rate of up to 70% of cases in type 1 virus. It is expected that the new treatment will help in treating many cases, especially since (1) is one of the most widespread factions in the Kingdom after type 4.
